Background N6-methyladenosine (m6A) modification is a critical epigenetic modification in
eukaryotes and involves several biological processes and occurrences of diseases …

Osteoporosis (OP) is a severe systemic bone metabolic disease that occurs worldwide.
During the coronavirus pandemic, prioritization of urgent services and delay of elective care …

Osteoporosis is a metabolic skeletal disorder in which bone mass is depleted and bone
structure is destroyed to the degree that bone becomes fragile and prone to fractures …

Abstract N6-methyladenosine (m 6 A) is the most prevalent modification in the eukaryotic
transcriptome and has a wide range of functions in coding and noncoding RNAs. It affects …

Osteoporosis is a prevalent bone disease of the aging population, which is characterized by
a decrease in bone mass because of the imbalance of bone metabolism. Although the …

This study investigated the effect of the N 6-methyladenosine (m 6 A)-associated SNPs on
bone mineral density (BMD) and found plenty of m 6 A-SNPs that were associated with …

Abstract N 6-methyladenosine (m 6 A), a novel epitranscriptomic RNA modification, plays
crucial roles in a variety of biological processes and diseases. Recently, there are growing …

Abstract N6-methyladenosine (m6A) is the most abundant posttranscriptional methylation
modification that occurs in mRNA and modulates the fine-tuning of various biological …

The methylation of adenosine base at the nitrogen-6 position is referred to as “N6-
methyladenosine (m6A)” and is one of the most prevalent epigenetic modifications in …

Background Postmenopausal osteoporosis (PMOP) is a common bone disorder. Existing
study has confirmed the role of exosome in regulating RNA N6-methyladenosine (m6A) …